Products and Services

Products and Services

Active Pharmaceutical Ingredients


Ausun

Product Name

CAS Number

Specification

DMF

CEP

Status

CN

PV

Osimertinib mesylate

1421373-66-1

In-house

Q4 2025

Palbociclib

571190-30-2

In-house

Ruxolitinib (Phosphate)

941678-49-5&1092939-17-7

In-house

Trametinib dimethyl sulfoxide

1187431-43-1

In-house

Q4 2025

Tofacitinib Citrate

540737-29-9

In-house

Acalabrutinib

1420477-60-6

Q1 2027

Q3 2026

Avapritinib

1703793-34-3

Q2 2027

Q4 2026

Capivasertib

1143532-39-1

Q3 2027

Q1 2027

Capmatinib

1029712-80-8

Q3 2027

Q1 2027

Darolutamide

1297538-32-9

Q1 2027

Q3 2026

Encaofenni

1269440-29-0

Q1 2027

Q3 2026

Filgotinib Maleate

1802998-75-9

Q1 2027

Q3 2026

Gilteritinib

1254053-43-4

Q1 2027

Q3 2026

Inavolisib

2060571-02-8

Q1 2027

Q3 2026

Lorlatinib

1454846-35-5

Q2 2027

Q4 2026

Niraparib

1038915-60-4

Q2 2027

Q4 2026

Pirtobrutinib

2101700-15-4

Q2 2027

Q4 2026

Rimebutinib

1787294-07-8

Q3 2027

Q1 2027

Ritlecitinib

1792180-81-4

Q1 2027

Q3 2026

Selumetinib

606143-52-6

Q1 2027

Q3 2026